Related Experiment Video
Updated: May 14, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
ART Interrupted: Insights into ART-free HIV remission
1Virus Persistence and Dynamics Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Abstract:
Defining correlates of HIV rebound upon antiretroviral therapy (ART) interruption can advance HIV cure research. In this issue of Immunity, Ma et al. analyze immunophenotypes and transcriptomes from multiple clinical trials, linking T and NK cell subsets to delayed rebound and identifying DDIT4 and ZNF254 as HIV silencing factors. The antidiabetic drug metformin induces DDIT4 and silences HIV in vitro.
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections
Retroviruses
Viral Hepatitis I: Introduction
